Six-Year Ban: Ruti Aga's Case Shows the Real Enemy in Marathon Is Not Doping But the Medical-Support Gap

In March last year, Ruti Aga won a half marathon in China. The sample she gave afterwards came back positive. The Athletics Integrity Unit's statement on Thursday separates two findings cleanly — two years for the presence of methylprednisolone, four years for a forged prescription. Add them and you get six.

Read that as a doping story and you will miss the story that was actually written.

I first saw the distance between an athlete's medical file and the media narrative in 2026, in the mixed zone at the Asian Athletics Championships in Bhubaneswar, working as a bilingual volunteer. I did not understand then that this gap would one day consume a career. Aga's case is that gap in its mature form.

The statement and the bare facts

According to the AIU, Aga took methylprednisolone to treat a knee injury. The drug was allegedly supplied by a family member with no medical registration, who claimed to have used an old prescription pad from a former workplace. The clinic named in the investigation does not exist. The clinic explicitly disowned the pad.

Three independent verification failures. That is not coincidence.

Aga's record includes three second-place finishes at World Marathon Majors and the 2026 Tokyo Marathon title. She belongs to the generation that made Tokyo its lifeline. A six-year ban starting 10 September means she would return at roughly 38 — and in the depth of Ethiopian women's marathoning, a 38-year-old returnee is effectively unselectable.

The real issue is not the drug but who delivered it

Methylprednisolone is a glucocorticoid, not an anabolic steroid. WADA's Prohibited List places it in class S9, prohibited in-competition only, by injection, oral or rectal route. In plain terms: a legitimate knee injection out of competition is entirely legal. The violation occurs when residue remains in the sample on race day.

This matters because Aga had a legitimate defence available — timing, route, documented medical necessity. With real records, the presence charge plausibly lands at the no-fault end, and no tampering charge exists at all. The forged prescription is evidence that no real record existed. The media frame that reads 'steroid ban' misdescribes what happened. The six years are mostly for the lie told to cover the drug, not the drug.

Watching elite fields at the Mumbai Marathon, I learned that the absence is rarely a coach or an agent. Athletes have those. What they lack is a credentialed team physician. Running a marathon on a painful knee is an athlete's stubbornness; the cheapest way to suppress that pain is a glucocorticoid injection. The need is not wrong. The lie is what is wrong.

The sanction arithmetic reveals the logic

Two years plus four years. The two-year figure typically signals a Specified Substance finding without proven intent. Four years is the Code's standard tampering sanction. The arithmetic tells us the panel accepted presence without conspiracy, but treated the fabricated document as fully culpable.

A counter-intuitive reading follows: forged documentation is itself circumstantial evidence of concealment intent — so why did it not escalate the presence sanction? Because document-based and substance-based charges run on separate tracks and are not stacked to inflate. That is procedural fairness. Look at the result, though, and the sanction is career-terminal in size.

If she returns, where does she return to? No World Major organiser will invite her before 2032. The Chinese half-marathon circuit where the sample was collected still pays appearance fees — and AIU testing density is rising in exactly that tier. The appearance-fee economy and the testing economy now collide in the same races.

This case rhymes with a cluster of East African road-running cases: a substance first, a documentary lie second, a doubled sanction third. It happens for one reason. Athletes race elite; they do not have team doctors. When injury arrives, they go to whoever is nearby — family, training partner, an agent's acquaintance. The AIU charges the athlete, not the agent.

Why the system lags

The most uncomfortable truth here is that six years at 32 is functionally a lifetime ban. Many will read a six-year sanction for a glucocorticoid as disproportionate. I would call it incomplete rather than disproportionate. It would be disproportionate only if it also reached the team doctor who helped build the lie — and the record names only the family member.

And whichever way it reads, the races involved are not even an entry in Ethiopia's selection calculus. A 2:18 woman does not automatically make Ethiopia's women's marathon team. Aga's removal will not be felt in that depth. That is the saddest part of her story — the ban is nearly invisible in performance terms, and it is everything to her.

What comes next

When an agent next enters an Ethiopian marathoner in a label race, I hope the first question asked is whether a registered physician travels with the athlete. The first letter of Aga's sanction was not the drug. It was the absence of a real doctor beside a painful knee.

The AIU can verify documents. It cannot verify medicine. Until medical support becomes an institutional responsibility in elite road running, forged prescriptions will keep arriving — and the athlete will keep being the first to be punished for having no other option in front of her.

Sometimes the question is not what an athlete took. It is what she had.